VKORC1L1 contributes to glioblastoma progression and temozolomide resistance by sustaining vitamin K reduction and limiting ferroptosis-associated lipid peroxidation.

Authors

Yao-Wen Hu, Hai-Long Du, Wen-Jian Zhen, Xin Gong, Jian-Kai Yang

Published in

Tissue & cell. Volume 104. Issue Pt 3. Pages 104057. Oct 13, 2026. Epub Oct 13, 2026.

Abstract

To investigate the expression and functional role of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) in glioblastoma (GBM) progression and temozolomide (TMZ) resistance.
VKORC1L1 expression and its associations with recurrence and overall survival were analyzed in the Chinese Glioma Genome Atlas. TMZ sensitivity and VKORC1L1 expression were examined in five GBM cell lines. VKORC1L1 was silenced in T98G cells, followed by evaluation of cell viability, migration, invasion, colony formation, ferroptosis-related markers, and the rescue effects of ferrostatin-1 (Fer-1). MK-4 and MK-4H₂ levels were quantified by LC-MS/MS, and TMZ sensitivity was determined by dose-response analysis. The effects of VKORC1L1 knockdown combined with TMZ were further examined in a T98G xenograft model.
In the CGGA cohort, VKORC1L1 expression was elevated in recurrent gliomas and was associated with shorter overall survival. T98G cells showed the highest VKORC1L1 expression and greatest relative TMZ resistance among the five cell lines. VKORC1L1 knockdown increased ACSL4, lipid hydroperoxide, Fe²⁺, and 4-hydroxynonenal levels and suppressed T98G cell proliferation, migration, invasion, and colony formation, which were partially reversed by Fer-1. VKORC1L1 knockdown reduced MK-4H₂ generation and the MK-4H₂/MK-4 ratio and decreased the TMZ IC₅₀ from 623.7 μM in shNC cells to 351.4 and 398.4 μM in shVKORC1L1#1 and shVKORC1L1#2 cells, respectively. Fer-1 partially reversed this TMZ sensitization. In vivo, combined VKORC1L1 knockdown and TMZ treatment produced the smallest tumors, lowest Ki-67 index, and highest intratumoral 4-hydroxynonenal and Acsl4 expression.
VKORC1L1 contributes to GBM malignant behavior and TMZ resistance by sustaining vitamin K reduction and limiting ferroptosis-associated lipid peroxidation. These findings suggest that disruption of VKORC1L1-mediated vitamin K reduction may represent a potential strategy for enhancing TMZ sensitivity through increased ferroptosis-associated lipid peroxidation.

PMID:
42913186
Bibliographic data and abstract were imported from PubMed on 24 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.